3.86
Bioharvest Sciences Inc Borsa (BHST) Ultime notizie
Tate & Lyle Expands Collaboration with BioHarvest Sciences to Accelerate Next-Generation Sweetener Innovation - TMX Newsfile
Bioharvest Sciences Signals Progress Amid Near-Term Losses - TipRanks
BioHarvest Sciences and Tate & Lyle expand sweetener development program - Proactive financial news
BioHarvest (BHST) Q1 2026 Earnings Transcript - AOL.com
BioHarvest expands Tate & Lyle sweetener development deal By Investing.com - Investing.com Australia
Tate & Lyle expands plant-based sweetener innovation partnership with BioHarvest Sciences - New Food
BioHarvest expands Tate & Lyle sweetener development deal - Investing.com UK
New plant-based sweeteners aim to cut sugar in more foods - Stock Titan
BioHarvest Sciences Q1 earnings call highlights - MSN
BioHarvest outlines 2026 revenue of $38M-$42M in D2C and $12M-$14M in CDMO activity while targeting 2H 2027 fragrance production - MSN
H.C. Wainwright Maintains BioHarvest Sciences(BHST.US) With Buy Rating, Maintains Target Price $14 - Moomoo
BioHarvest Sciences Inc. Common Stock Q1 2026 Earnings Call Summary - Yahoo Finance
BioHarvest Sciences Inc (BHST) Q1 2026 Earnings Call Highlights: Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
BioHarvest Sciences Inc (BHST) Q1 2026 Earnings Call Highlights: - GuruFocus
BioHarvest Sciences (NASDAQ:BHST) Announces Quarterly Earnings Results - MarketBeat
BioHarvest Sciences Inc. (BHST) reports Q4 loss, lags revenue estimates - MSN
BioHarvest Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
BioHarvest Sciences Posts Q1 2026 Growth and Advances Botanical Synthesis Deals - TipRanks
BioHarvest Sciences: Q1 revenue up 8% YoY, CDMO revenue up 135%, net loss at $2.6M, gross margin at 59% - TradingView
BioHarvest Sciences (NASDAQ: BHST) posts Q1 2026 growth with $8.5M revenue - Stock Titan
Small cap wrap: VivoPower, BioHarvest Sciences, Phunware, Tiziana Life Sciences… - Proactive financial news
BioHarvest Sciences Files Q1 2026 Financials on Form 6-K - TipRanks
BioHarvest Sciences Q1 2026 Earnings Call Transcript - MarketBeat
BioHarvest Sciences (NASDAQ: BHST) grows Q1 2026 revenue while warning on going concern - Stock Titan
BioHarvest Sciences Names New Business Development Chief to Drive CDMO Growth - TipRanks
BioHarvest Sciences: Q1 revenue up 8% to $8.5M, CDMO and D2C segments advance, 2026 outlook reaffirmed - TradingView
New CDMO business development leader joins BioHarvest Sciences (NASDAQ: BHST) - Stock Titan
BioHarvest Sciences Q1 Earnings Call Highlights - MarketBeat
BioHarvest Sciences: Q1 2026 revenue up 8% to $8.5M; key CDMO and D2C milestones achieved; cash at $20.2M - TradingView
BioHarvest Sciences Inc. (BHST) reports Q1 loss, beats revenue estimates - MSN
BioHarvest Sciences Q1 revenue climbs as it expands botanical synthesis pipeline - Proactive financial news
BioHarvest Sciences : First Quarter 2026 Financial Statements - marketscreener.com
BioHarvest Sciences Inc. (BHST) Reports Q1 Loss, Beats Revenue Estimates - Yahoo Finance
BioHarvest Sciences: Q1 revenue up 8% year-over-year, driven by CDMO and VINIA growth; net loss at $2.6 million - TradingView
BioHarvest develops cell culture for endangered perfume ingredient in $1.2M pact - Stock Titan
BioHarvest appoints Salzman-Frenkel as VP business development - Investing.com UK
BioHarvest appoints Salzman-Frenkel as VP business development By Investing.com - Investing.com Nigeria
BioHarvest Sciences Appoints New Head of Business Development for its CDMO Division - marketscreener.com
Small cap wrap: TNR Gold, Power Metallic Mines, BioHarvest Sciences, Midnight Sun Mining… - Proactive financial news
BioHarvest Advances Saffron CDMO Program to Stage 2 After Completing Cell Bank Milestone - TipRanks
BioHarvest Sciences (NASDAQ: BHST) completes Stage 1 in $1.125M saffron deal - Stock Titan
BioHarvest advances saffron cell bank project to stage 2 By Investing.com - Investing.com India
BioHarvest Sciences advances synthetic saffron program with SaffronTech partnership - Proactive financial news
BioHarvest advances saffron cell bank project to stage 2 - Investing.com UK
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):